glp 1 iih Metabolic Dysfunction in Idiopathic Intracranial Hypertension: Current Theories and Updates Idiopathic Intracranial Hypertension: managing life
Description
2024;64(1):204-211 e204
A secondary analysis of the STEP-HFpEF and STEP-HFpEF DM trials involving 1145 obese T2DM-associated HFpEF patients showed that semaglutide reduced NT-proBNP levels and improved health status after 52 weeks [83]
y axis is the ratio of exposed area to buried area
, Shin, J
